Study wrapper · #195
Glycine-modified growth hormone secretagogues identified in seized doping material.
Editor's note
A forensic analytical-chemistry report, not a biological or clinical study, describing what customs authorities found in seized doping powders. Danish customs submitted unknown preparations for high-resolution mass spectrometry, and analysts identified them as glycine-modified analogues of the growth-hormone secretagogues GHRP-2 (pralmorelin), GHRP-6, ipamorelin and modified GRF 1-29 (a sermorelin-related peptide). The single, telling finding is that each carried an extra glycine amino acid added at the N-terminus, a deliberate structural tweak that would let a product evade routine anti-doping assays targeting the parent peptides. For our readers this is a product-integrity and adulteration signal rather than an efficacy or safety study: it documents that grey-market peptide material circulating as these compounds may be structurally altered and mislabelled, reinforcing well-established concerns about unregulated supply. The authors' operational conclusion is that detection methods should be updated to catch these modified variants. The relevant lesson is about what is actually in seized peptide product, not about any effect of ipamorelin or sermorelin themselves.
Plain-language abstract
This was a laboratory analysis of illegal drug powders, not a study of health effects. Danish customs seized several unknown pharmaceutical preparations and sent them for testing with a precise chemical identification method (high-resolution mass spectrometry). By comparing the powders with reference samples, analysts identified them as versions of growth-hormone-stimulating peptides used as performance enhancers in sport: GHRP-2 (also called pralmorelin), GHRP-6, ipamorelin, and a modified form of a sermorelin-related peptide (modified GRF 1-29). In every case, the peptides had been altered by adding an extra glycine (an amino acid) to one end of the molecule. This small change could help the products slip past standard anti-doping tests that look for the original, unmodified peptides. The authors concluded that testing methods should be updated to detect these glycine-modified versions. For readers, the key point is about product contents and mislabelling in the unregulated market: peptides sold under familiar names may be chemically altered, underscoring concerns about what such products actually contain.